Received: from AS8PR01MB8009.eurprd01.prod.exchangelabs.com (2603:10a6:20b:374::6) by GVXPR01MB11722.eurprd01.prod.exchangelabs.com with HTTPS; Thu, 23 Apr 2026 09:04:35 +0000 ARC-Seal: i=2; a=rsa-sha256; s=arcselector10001; d=microsoft.com; cv=pass; b=SNSon4qxpWbMEOb1twsO/ylBVuv2jnWSOyx2idoH+NcH9M2lxAcuearkM/GgA09xK+OE2v61gFvxQtSPRPxDPhUGAxFLT/Clnuj7siYc3H6VuEjW2mV22+enNQSDGANDOIpQHrX0pokaUCacRZIy12l2soMHAm03PopUJCHNgXY03SkXT5avZDttgbo2uGMzM+8dxpVP38Gtaf3N4RLfwqnYLBrFe7Ubr9Zl+Pg7TcUB84ouTve5ht8phTWy4A9eju0ySRw8vdRtwIzRrVb9nOXmvNtTMBxXNIwc1SE+CFjV4ilFZc82v1HGRTZy/4An9sK7+qmXv1ZRfL6ZECv1Hw== ARC-Message-Signature: i=2; a=rsa-sha256; c=relaxed/relaxed; d=microsoft.com; s=arcselector10001; h=From:Date:Subject:Message-ID:Content-Type:MIME-Version:X-MS-Exchange-AntiSpam-MessageData-ChunkCount:X-MS-Exchange-AntiSpam-MessageData-0:X-MS-Exchange-AntiSpam-MessageData-1; bh=n6tYi33xXaPrgt51Lx+SxxGw3lJkLyrzrp1Kl49cu3g=; b=n/gy4si1WamYlztkUxuilFZsJMb0rOCB34LGd4tZJbQ0YKJ7/uRhj3mHA++dM1U6GRPQGFlcdDcn15pthoGDfinDEpN6Yu2u8uVQAFizeoQmESmhiR953HlnOMbhOjTBLmGP0arq2jzDwI6DCIw5gwOLc8BonICJU/q34vDVbl5pJnKJaAi+8O/c5oCmiej6BQlIFxck3H83w0PaOptpITeYd4zUqn9igUQsf5yzfkUfw/1yrkCCkv2xKFab4WCustJ39Ny7izTeoR23PelqDACSyhzaPQGMBs9C7DtmkloWNmxs3aLhMWCjrtrjrt8Lnes9TvSizq2oPYpyMS7u5w== ARC-Authentication-Results: i=2; mx.microsoft.com 1; spf=pass (sender ip is 2a01:111:f403:c205::1) smtp.rcpttodomain=warwick.ac.uk smtp.mailfrom=hra.nhs.uk; dmarc=pass (p=reject sp=reject pct=100) action=none header.from=hra.nhs.uk; dkim=pass (signature was verified) header.d=hra.nhs.uk; arc=pass (0 oda=1 ltdi=1 spf=[1,1,smtp.mailfrom=hra.nhs.uk] dkim=[1,1,header.d=hra.nhs.uk] dmarc=[1,1,header.from=hra.nhs.uk]) Received: from CW1P302CA0024.GBRP302.PROD.OUTLOOK.COM (2603:10a6:400:297::13) by AS8PR01MB8009.eurprd01.prod.exchangelabs.com (2603:10a6:20b:374::6) with Microsoft SMTP Server (version=TLS1_2, cipher=TLS_ECDHE_RSA_WITH_AES_256_GCM_SHA384) id 15.20.9818.31; Thu, 23 Apr 2026 09:04:33 +0000 Received: from AM1PEPF000252DC.eurprd07.prod.outlook.com (2603:10a6:400:297:cafe::94) by CW1P302CA0024.outlook.office365.com (2603:10a6:400:297::13) with Microsoft SMTP Server (version=TLS1_3, cipher=TLS_AES_256_GCM_SHA384) id 15.20.9846.21 via Frontend Transport; Thu, 23 Apr 2026 09:04:33 +0000 Authentication-Results: spf=pass (sender IP is 2a01:111:f403:c205::1) smtp.mailfrom=hra.nhs.uk; dkim=pass (signature was verified) header.d=hra.nhs.uk;dmarc=pass action=none header.from=hra.nhs.uk;compauth=pass reason=100 Received-SPF: Pass (protection.outlook.com: domain of hra.nhs.uk designates 2a01:111:f403:c205::1 as permitted sender) receiver=protection.outlook.com; client-ip=2a01:111:f403:c205::1; helo=LO3P265CU004.outbound.protection.outlook.com; pr=C Received: from LO3P265CU004.outbound.protection.outlook.com (2a01:111:f403:c205::1) by AM1PEPF000252DC.mail.protection.outlook.com (2603:10a6:20f:fff4:0:3:0:6) with Microsoft SMTP Server (version=TLS1_3, cipher=TLS_AES_256_GCM_SHA384) id 15.20.9846.18 via Frontend Transport; Thu, 23 Apr 2026 09:04:33 +0000 ARC-Seal: i=1; a=rsa-sha256; s=arcselector10001; d=microsoft.com; cv=none; b=WYy8DpfI2J4RYMj2vG+ne+GoSswayBqUZNhcNqQ15U/1+HmtR/urV/L7TorsHqP+ugzbqOZnL1Zz5dUslMzYXtE9s2M1xVl6kNephTUpX5/D5p1qQ9hKQetqxjpYx/8YmUjejqpAgswmIeaa1EdHCyp8X7usTGD7K8knV0CBwc5fASJk6FTmc+8ijvdD7g+M00P4brI3tkMxP8/hYFkfIRB4MruVz3PNYfO8kojBTQbMaE+aEoM7ac8Js3QZ/fzhTXnDx/dUh2+KqX1SmPQrupOayFLH61EfutNmu78URVprDnI1ElQ2WBpnbgQYHY8S5Wx7//8Z0aEhvzAjEgTx9A== ARC-Message-Signature: i=1; a=rsa-sha256; c=relaxed/relaxed; d=microsoft.com; s=arcselector10001; h=From:Date:Subject:Message-ID:Content-Type:MIME-Version:X-MS-Exchange-AntiSpam-MessageData-ChunkCount:X-MS-Exchange-AntiSpam-MessageData-0:X-MS-Exchange-AntiSpam-MessageData-1; bh=n6tYi33xXaPrgt51Lx+SxxGw3lJkLyrzrp1Kl49cu3g=; b=OFtBKHnEIm9ATGhlzyotdwd4ucFY9b+DYde9MajXD+HzoJrnyywRBdN+P6otGwCzjmwIe04GLX8TqyC3gIk632J7wewmh8knlCIN0TSo2231IFpKkhwbFzFBWN6ek3V+WjMVl6V8FccSkuX9HITcm74wLYg6EstTJWmBWXilzn+jivOMHtiEgvAqRvEjv3FCIBqw0ZB8t96aIMfNGJk07ZNEYfiE8k7QYLaMQNbsvKovAEsSGAwMatVu8y+3h6KPxBAoL5RMJWRaOUrmAGcD+ZBz2O2MDjZ66jI71DC6i0mP6O+vSXrz/MTTunqpFyfgJVP+gQTLI8Oivd8jcLAHUw== ARC-Authentication-Results: i=1; mx.microsoft.com 1; spf=pass smtp.mailfrom=hra.nhs.uk; dmarc=pass action=none header.from=hra.nhs.uk; dkim=pass header.d=hra.nhs.uk; arc=none DKIM-Signature: v=1; a=rsa-sha256; c=relaxed/relaxed; d=hra.nhs.uk; s=selector1; h=From:Date:Subject:Message-ID:Content-Type:MIME-Version:X-MS-Exchange-SenderADCheck; bh=n6tYi33xXaPrgt51Lx+SxxGw3lJkLyrzrp1Kl49cu3g=; b=LQAbzo1qAjcjIEqlKEV9YTRnqEVtgYi3wtGhu4gksf1+6BFlp0fgeun8g5Y+chKXWiRhgDPRX57jhCBCCpmLkcSr92Mkp5P5eom3XR+E+Ri+2dPNcaxUtSG6r7susIDcfe2L+mGobAyDJGxQ1RusMMdAvMr3udopLExaAHekmS04sEXzwUsKh856Fs/NAga/NUB5vju5bb7l6iyFK2HblW7HrVmSqJS2vLu49Ur886nz9AtcV2AcxC2K/ode6GVuwp3Q8Hy9z9n3UCco1hrAgU+HJq5Qd8PHjB8FIeoxalHrZU6kkrrVwDmRR7o7oBDHBQSdrYmiDlR99iiPVWIbXA== Received: from LO0P302MB0209.GBRP302.PROD.OUTLOOK.COM (2603:10a6:600:365::10) by CW1P302MB2076.GBRP302.PROD.OUTLOOK.COM (2603:10a6:400:263::11) with Microsoft SMTP Server (version=TLS1_2, cipher=TLS_ECDHE_RSA_WITH_AES_256_GCM_SHA384) id 15.20.9846.21; Thu, 23 Apr 2026 09:04:29 +0000 Received: from LO0P302MB0209.GBRP302.PROD.OUTLOOK.COM ([fe80::ceb2:f3cc:ba12:542a]) by LO0P302MB0209.GBRP302.PROD.OUTLOOK.COM ([fe80::ceb2:f3cc:ba12:542a%5]) with mapi id 15.20.9846.021; Thu, 23 Apr 2026 09:04:29 +0000 From: no-reply-IRAS To: "sis@warwick.ac.uk" Subject: IRAS 316755. Amendment Thread-Topic: IRAS 316755. Amendment Thread-Index: AQHc0wAx9/V1snx6BU2z6ACJQgJR7Q== Date: Thu, 23 Apr 2026 09:04:29 +0000 Message-ID: Accept-Language: en-GB, en-US Content-Language: en-US X-MS-Has-Attach: X-MS-TNEF-Correlator: Authentication-Results-Original: dkim=none (message not signed) header.d=none;dmarc=none action=none header.from=hra.nhs.uk; x-ms-traffictypediagnostic: LO0P302MB0209:EE_|CW1P302MB2076:EE_|AM1PEPF000252DC:EE_|AS8PR01MB8009:EE_|GVXPR01MB11722:EE_ X-MS-Office365-Filtering-Correlation-Id: 04adea84-744f-4afd-182c-08dea1175649 x-ms-exchange-senderadcheck: 1 x-ms-exchange-antispam-relay: 0 X-Microsoft-Antispam-Untrusted: BCL:0;ARA:13230040|1800799024|366016|376014|19092799006|8096899003|18002099003|38070700021|56012099003; X-Microsoft-Antispam-Message-Info-Original: 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 X-Forefront-Antispam-Report-Untrusted: CIP:255.255.255.255;CTRY:;LANG:en;SCL:1;SRV:;IPV:NLI;SFV:NSPM;H:LO0P302MB0209.GBRP302.PROD.OUTLOOK.COM;PTR:;CAT:NONE;SFS:(13230040)(1800799024)(366016)(376014)(19092799006)(8096899003)(18002099003)(38070700021)(56012099003);DIR:OUT;SFP:1101; X-MS-Exchange-AntiSpam-MessageData-Original-ChunkCount: 1 X-MS-Exchange-AntiSpam-MessageData-Original-0: =?us-ascii?Q?BnzMWGLwpzv220QCo2GqmUnRkL2ly/tOM0W+T4GgxNzckcKv7tyGPooi62Eg?= =?us-ascii?Q?KddKExY49GW1t6+BVCC/v88ocWcB/CTkxQ3hXnx0fURVp9kCA1ttbp35Kq04?= =?us-ascii?Q?m1CvLuH3bMTBGfNXLmClsALSXdTcbSpxVa0a+6TC3zLfUmGN1rGcEgNj+TxQ?= =?us-ascii?Q?IR8JJHPTxCwj9R8EGpBrPjmsb+yn/Doui0FhzKZC11QU9Ig+mzudqlM9guZh?= =?us-ascii?Q?+zlRJfK6zptZFZg4dyTQUIXftBlXTuN4fl3QI2aTHVGUt5HljHwj+Sni9VNh?= =?us-ascii?Q?ICjFekDVNSuaeasdkawF/jyQU6Ko7lr2Sxd54EYxi/nAOMlZiVxOHIAbmqxS?= =?us-ascii?Q?wQi0LOW+fx7ruhHzL/aIm8CtMfJpX5algQ/VDXoH0oOfaN/I/8KhXEF0SJUp?= =?us-ascii?Q?kZZFEileNO20BtS92eYdGnAN+aN6ImQ8oQGWX0kwcJrLpChsaXa+M9xGXR+z?= =?us-ascii?Q?Lj+7t0PnohzEgJXvTenY1mBNTViHRfBusG1sB8AX6LBT/NvRug9pLumG5xiM?= =?us-ascii?Q?u2eB7+BCzoE9NwadtCWahKHlzpxQBdjURvF4vmnbD0/i89PCbNlVIKXmFUyS?= =?us-ascii?Q?H7lrhQDWMNYpXpH4s2JPlgNvz3dexZe2B/XXL8RY/XZZ1ArbF8zVHpPNQDRL?= =?us-ascii?Q?d6vWQIu2V9MBfe1piiE9Q1O5ZVDD87tlQT4AKWn4/4aP3vsJJPOzto6VDBiA?= =?us-ascii?Q?j6u0Rq5KAfV1toMdjYVjcwf8cS6TC2ciBhuzPyxdEvx5B3OZ31TTI5wws9Zm?= =?us-ascii?Q?vKITmuXoBF1Azs7+CZxw47d574i2DGKL5tveuXkaB36URRI87B7KYrUMwYkj?= =?us-ascii?Q?aq/3DwFSHZTKB7TantBqxihOsRKpG+5RlQs2KhlQpko+2exmVlhPJ1w2+b2I?= =?us-ascii?Q?LiULCMavVDqCMNCE5xpzsvDrvHSbeIjP862ZY8qfmw/Tyn7IFQXL9Cv5h+12?= =?us-ascii?Q?2TRGyYyPezEk1uVIwp/4CBtE1AP+dOYv6CpNAatqt4toWXrXuB4hVYbw3FE7?= =?us-ascii?Q?dWKpRX6hpGpCsQjS8i9vlCGhDtVKTopoqb4vJUXhVp9Gak+NwaxWi30bNcSN?= =?us-ascii?Q?ZKFbN6RJo/FHdR5oIy+Uxra8XX9Nha/cCHE5mOI6kwAdIOztre//txiXFOQN?= =?us-ascii?Q?pwBGld6Pe9Qj+7AmZiNFmAwNY/r0lTiHdqlu3c5TEibEppnemDx5/q40UuM5?= =?us-ascii?Q?WmMIcKogw+iSCP/OW7OkvAOKk5eRigw7BGguM20752H7frnOEfaGyd7BDmqB?= =?us-ascii?Q?nBSG8JqIWvqm6a8w3GMU2dmxwZ4JYHwivPtFIf4ZYmz/YXz5c2cdWuZuqPwS?= =?us-ascii?Q?qKzbT2LS1M1C47nEx86MECFt9dnjsLzxSt1l3kV/f6LSmsfMrbmyXCE7pd17?= =?us-ascii?Q?6ZxW+kjfFcx72EL0EpSGro00TDG+n3t6QfluaPBaaLAUJA+M6q1Inoz/MCPa?= =?us-ascii?Q?13Sq/99aZLiLgH4oqOeiLuQeUvhWfYlwC3p0GIaLywnkoFjSEqAAfOyMQkUq?= =?us-ascii?Q?tNtqNP1uUNF0SHyN58tagmFGpVBtVvmpXHveA7s9yBhlOjwHS9mDYf33MkYZ?= =?us-ascii?Q?cd2KhIXTM+6GQffMOcn+WFWJc8iUghKHw5fx0pk6QJMYxCR094TrcJ99evWZ?= =?us-ascii?Q?FwhKvYEkCIioQMK9XxdBNdL6D26uNCeqvX2FCzVtZ1vXjydlYDIjwnEiYZfI?= =?us-ascii?Q?JW6Lp1o8A9KBpWMhOsjIZlFAkXulm5Z6T6jsqcGiIvvTquBm3DaIM759Amap?= =?us-ascii?Q?ygN0Uy8IJ6VqubVjAeBmHZ4cc5dv1rc=3D?= Content-Type: multipart/alternative; boundary="_000_LO0P302MB0209A690B3032C2FCF9E8C22902A2LO0P302MB0209GBRP_" X-MS-Exchange-Transport-CrossTenantHeadersStamped: CW1P302MB2076 Return-Path: no-reply-iras@hra.nhs.uk X-MS-Exchange-Organization-ExpirationStartTime: 23 Apr 2026 09:04:33.7139 (UTC) X-MS-Exchange-Organization-ExpirationStartTimeReason: OriginalSubmit X-MS-Exchange-Organization-ExpirationInterval: 1:00:00:00.0000000 X-MS-Exchange-Organization-ExpirationIntervalReason: OriginalSubmit X-MS-Exchange-Organization-Network-Message-Id: 04adea84-744f-4afd-182c-08dea1175649 X-EOPAttributedMessage: 0 X-EOPTenantAttributedMessage: 09bacfbd-47ef-4465-9265-3546f2eaf6bc:0 X-MS-Exchange-Organization-MessageDirectionality: Incoming X-MS-Exchange-Transport-CrossTenantHeadersStripped: AM1PEPF000252DC.eurprd07.prod.outlook.com X-MS-Exchange-Transport-CrossTenantHeadersPromoted: AM1PEPF000252DC.eurprd07.prod.outlook.com X-MS-PublicTrafficType: Email X-MS-Exchange-Organization-AuthSource: AM1PEPF000252DC.eurprd07.prod.outlook.com X-MS-Exchange-Organization-AuthAs: Anonymous X-MS-Office365-Filtering-Correlation-Id-Prvs: eefa016a-aec8-4c29-d1b4-08dea11753da X-MS-Exchange-AtpMessageProperties: SA|SL X-MS-Exchange-Organization-SCL: 1 X-Microsoft-Antispam: BCL:0;ARA:13230040|704160611799003|35042699022|12012899012|16102099003|56012099003|19002099003|18002099003|8096899003|55112099003; X-Forefront-Antispam-Report: CIP:2a01:111:f403:c205::1;CTRY:;LANG:en;SCL:1;SRV:;IPV:NLI;SFV:NSPM;H:LO3P265CU004.outbound.protection.outlook.com;PTR:mail-uksouthazlp170100001.outbound.protection.outlook.com;CAT:NONE;SFS:(13230040)(704160611799003)(35042699022)(12012899012)(16102099003)(56012099003)(19002099003)(18002099003)(8096899003)(55112099003);DIR:INB; X-MS-Exchange-CrossTenant-OriginalArrivalTime: 23 Apr 2026 09:04:33.6669 (UTC) X-MS-Exchange-CrossTenant-Network-Message-Id: 04adea84-744f-4afd-182c-08dea1175649 X-MS-Exchange-CrossTenant-Id: 09bacfbd-47ef-4465-9265-3546f2eaf6bc X-MS-Exchange-CrossTenant-AuthSource: AM1PEPF000252DC.eurprd07.prod.outlook.com X-MS-Exchange-CrossTenant-AuthAs: Anonymous X-MS-Exchange-CrossTenant-FromEntityHeader: Internet X-MS-Exchange-Transport-CrossTenantHeadersStamped: AS8PR01MB8009 X-MS-Exchange-Transport-EndToEndLatency: 00:00:01.8532819 X-MS-Exchange-Processed-By-BccFoldering: 15.20.9846.017 X-Microsoft-Antispam-Mailbox-Delivery: ucf:0;jmr:0;auth:0;dest:I;ENG:(910005)(944506478)(944626604)(920097)(930201)(20251009189)(140003)(1420198); X-Microsoft-Antispam-Message-Info: =?us-ascii?Q?u07TWFO8Am5t4iKMFbAN5Fa9XG89A5h8gZPN6llS+84/vum2J77iUCh/Gje2?= =?us-ascii?Q?a6LxdyV8fk+3wySeI3jinKaR4kwlKjMrhw//5FodU27r+hyb03+Fg/a9iACe?= =?us-ascii?Q?84AE3rf1dZhxoclbk79AVMSR1CTPOC1Uk3L/oMrW85KXjy2lsric6QuF3/9i?= =?us-ascii?Q?YslKDhCzBQiPm7qAk5YgJJ20Mqm/33Y8LyIR3JIwq8VviLWvvujPWeto9MHC?= =?us-ascii?Q?nAjt8P8nHEnkdflXebx4gQ2g7dQO6jBdDedjQaZ2/+3YcS73M3zbCGPRKl6J?= =?us-ascii?Q?MEDEVRs1F8eniNyVH4LhLjTpvJ5lGFDkDbb9pDp7sGtDM9OaP/82yaZxU3Cs?= =?us-ascii?Q?3rLfDY9jwFcZR2Sm82DNqXKTscZoJEsgWCF3K/ZpMRtBak5HJOStZ5lVwmix?= =?us-ascii?Q?+1qmeWELcQHK6ZGfBgoTWbk5CLH5S12E/4ujxLbytR1NeXoXEiwy5Dxvw/U0?= =?us-ascii?Q?9rrkUFVfSWTr+8WgNs3wWFkWrk197Iu6vRRFW3xeIaEwXGf9PaTdCFXHRPk8?= =?us-ascii?Q?svoDsgC1UnRJde6x4E0EnKCs7rd7p2ewJg6VRsmj/ed/jvzCok633paggFO0?= =?us-ascii?Q?eipj58twFYwHk+avGFab8iG0Q9X+AU/FIZTBfq6ajkz5r8kalevbzi6U2bjk?= =?us-ascii?Q?INNVk90+Mc9Q5Zc3nXleyCwlV0so4oV+KVUp0iFwL9l72QHde7ce3PY0rvc4?= =?us-ascii?Q?w4oO2Xo9tERDsGBBjSciFz1mzGs/6YthlJ/dtj+3kYXcF2/YpMfBXBfubr+F?= =?us-ascii?Q?KxHujtZZQdicZYoCiT5/+dFlyBZ16YltsC1Sqx/K2ioFnKgQ7mRPxTpJI28+?= =?us-ascii?Q?4r882I/kERfdEo1C9RFFLBAkITiO1D6Pity1Q+JaixTxf74S6cegjDBwtnG6?= =?us-ascii?Q?MYrW/na3dNeSP6Tpelk88ilGYEX+sjndqRd6HSnNlr5d6/xynhG39xXcdaMD?= =?us-ascii?Q?q1iXC9cnqR8oQk7OLUlFmxhrw97GILCAZygHJyM8ln+YdXvWjXPwkdSzazcf?= =?us-ascii?Q?qIaYxR6PmZv+dLa8fLog7Uv7vEeYRQFUYfDtt6QISOKxKIW0F82MD3m7xYRp?= =?us-ascii?Q?bE6Ayqk435YZGz2rA6G2clxqceFYvtbmLBgsyTFX6xsTgoylZBculBy/Zlof?= =?us-ascii?Q?LnG6IAElfnJiJ9XG1a8ROw2PXhS5neDbLLZJCubk4t9pmSJj6BjIHuXT7/UF?= =?us-ascii?Q?bBnEuh818AFh33dFrand1jDMhujchaTMUB/Ftpo6xfo3Y2yYm+sOvYyj5FeV?= =?us-ascii?Q?MdTMNwxXArf+P6fOKiKPpZ9ttxzG+V/lK2RAT6/MZXRqP8DJqfp7pDTgS7Kc?= =?us-ascii?Q?dtOFTpR4gAgyAXvFKdjnZ77bX/I613h1l3R4K3w/eQT0UVjMWmi0BwJCC5G7?= =?us-ascii?Q?XbjnUIL6D7io257B+4UQSajiAwYui8JxPolCN17fFbisYhmod5i0+l3YW+6m?= =?us-ascii?Q?8WfQ4z6w2U3syGclyr2YMJf46+CgiejwUhQmvP4O/+t7DiJi+udTyrWDjNLn?= =?us-ascii?Q?8h6kP/FP/ZRxgMcrzc35nE009Uz+czKCOMI9/wBGTeBHUopHDDI3eIQyvzrj?= =?us-ascii?Q?Y8nUJWK/ZAYqkdmS6CfuxcOPc7WwB3SkN45Leer/cwvjKwJxRo6ni7WufuIY?= =?us-ascii?Q?KbTSGsyj3ivDOamwkEUVnlGdHeFt157SfQ8sAffv41yJ9Hzdkkfy2VWUozBT?= =?us-ascii?Q?vErddyh/oOfSMlzZcOicYrvp4otKsPTyhDTb9rdyaHkOyxiEUrQH0k9c7xUy?= =?us-ascii?Q?hKJiTglFo8NpQBJC66xHFGaMqyo9hjPbGjbFI6S/UlrzM1T1g0wQuofRKx1F?= =?us-ascii?Q?o/WgqP1SmZI61MElZx8m0E/vTu8LiWW54Xg0J+ll5hojbN/n8Tlk+Y8mvaO3?= =?us-ascii?Q?3jvcKFSfOpOeQeHZJclaaWUsTE/ZrQT2QCypvGeki/oCv80Z4d3xRuKKVY7X?= =?us-ascii?Q?c19F7vVzxTeO2WSO78Kxfw8j9/MyPnn4EqksH0cGBAGCP+Au346Ey4WL9ZDV?= =?us-ascii?Q?LHrYDVuNb4TSY5GOYKJA92ulCyuRT8/amWABDOYRzR+/odB+qzdkv53X2GHt?= =?us-ascii?Q?4gSvjNjZR3fjb/eg+c5mgoPwCyipROBfcH5C3G7tWzfPhxWyVXEnjKQJNR51?= =?us-ascii?Q?nWjf0VWom4fZUEBLX7TBg5r+bpfB+mfWMAgsI8qojeXa5Glz+BGDu50aciiE?= =?us-ascii?Q?hCwcW9HwqUWx5dtFjQuSiSdOmAIKqtuOG8wE3G7D1btJ2PU/hnq/RRTJxzAa?= =?us-ascii?Q?TtK2pN7JQ2ClLS++aC3CVzzOKgJhTx40HNx2W1OFilWH2+3+SS+WFhkFLCzo?= =?us-ascii?Q?dBB+RWYi4/CGAiVb6FKdPlQjCS/l7xEDH+Qgt3jqnB6xzWszYYl6E7TW3I35?= =?us-ascii?Q?f0l9MOo4vztKwGy7she1qOnleA1lpm3owf3/FK/QO1e5YJU52qDNurTkVTB8?= =?us-ascii?Q?sh0I7B0cbbJxqyqkCKCWv2rR65Rah0cpHcmqI//MPak0NHXHygLcUaLdbIco?= =?us-ascii?Q?t5FE7cReMYm6i3vLMKt4BcDrLHXJqFeRKOynOh8njD4POki8qPVd7KQP16aE?= =?us-ascii?Q?AIIQRA5ZN5tZGIR15bpw1stwSV9dCYvN3gJH0ByoJR1JBHgBpSYL3cmiR6Tt?= =?us-ascii?Q?ZWWmSl7LGMxZGxOTQPgidvPI7gQSzr/DRno+dMp1ATH9qjRtA0FvFkrgZ/Un?= =?us-ascii?Q?1B3KMfyRWFlVjSW9VtPm8yhopkKQG0hmlD8T8qYmnkP1MA1LpD4UQBZRMCcJ?= =?us-ascii?Q?23Y3NtO6IMx3o6mJ0RQmdoyq7oLoK6fAwjn6LzaWvkz3IqXt7awpPutd5WFW?= =?us-ascii?Q?iZBrDQiOonqah3xwUgDlylLq0k37s7RA//k=3D?= MIME-Version: 1.0 --_000_LO0P302MB0209A690B3032C2FCF9E8C22902A2LO0P302MB0209GBRP_ Content-Type: text/plain; charset="us-ascii" Content-Transfer-Encoding: quoted-printable IRAS Project ID: 316755 Sponsor amendment reference: NSA 25 Thank you for submitting your study amendment. In accordance with the outc= ome of your completed amendment tool, this amendment requires no further re= gulatory review. Please now share this amendment with your UK research site= s, in accordance with the instructions in your completed amendment tool. For studies with more than one UK research site, your amendment will now be= automatically shared with the R&D offices of any NHS/HSC research sites in= Scotland, but you should share the amendment by email directly with those = Research team/s. For all NHS research sites in England, Wales and Northern Ireland, please n= ow share this amendment by email directly with those sites, including both = the R&D offices and research teams. Do not reply to this email as this is an unmonitored address and replies to= this email cannot be responded to or read. ________________________________ This message may contain confidential information. If you are not the inten= ded recipient please inform the sender that you have received the message i= n error before deleting it. Please do not disclose, copy or distribute info= rmation in this e-mail or take any action in relation to its contents. To d= o so is strictly prohibited and may be unlawful. Thank you for your co-oper= ation.. ________________________________ --_000_LO0P302MB0209A690B3032C2FCF9E8C22902A2LO0P302MB0209GBRP_ Content-Type: text/html; charset="us-ascii" Content-Transfer-Encoding: quoted-printable IRAS 316755. Amendment

¹û¶³´«Ã½


IRAS Project ID:              &n= bsp;             316755  
Sponsor amendment reference: NSA 25 


Thank = you for submitting your study amendment.  In accordance with the outco= me of your completed amendment tool, this amendment requires no further regulatory review. Please now share this amendmen= t with your UK research sites, in accordance with the instructions in your = completed amendment tool.

For studies with more= than one UK research site, your amendment will now be automatically shared= with the R&D offices of any NHS/HSC research sites in Scotland, but yo= u should share the amendment by email directly with those Research team/s.

For all NHS researc= h sites in England, Wales and Northern Ireland, please now share this amend= ment by email directly with those sites, including both the R&D offices= and research teams.

Do not reply to this = email as this is an unmonitored address and replies to this email cannot be= responded to or read.

This message may contain confidential information. If you are not the inten= ded recipient please inform the sender that you have received the message i= n error before deleting it. Please do not disclose, copy or distribute info= rmation in this e-mail or take any action in relation to its contents. To do so is strictly prohibited and ma= y be unlawful. Thank you for your co-operation..
--_000_LO0P302MB0209A690B3032C2FCF9E8C22902A2LO0P302MB0209GBRP_--